Cite
Dethroning the king?: The future of metformin as first line therapy in type 2 diabetes.
MLA
Inzucchi, Silvio E., and Vivian Fonseca. “Dethroning the King?: The Future of Metformin as First Line Therapy in Type 2 Diabetes.” Journal of Diabetes & Its Complications, vol. 33, no. 6, June 2019, pp. 462–64. EBSCOhost, https://doi.org/10.1016/j.jdiacomp.2019.03.003.
APA
Inzucchi, S. E., & Fonseca, V. (2019). Dethroning the king?: The future of metformin as first line therapy in type 2 diabetes. Journal of Diabetes & Its Complications, 33(6), 462–464. https://doi.org/10.1016/j.jdiacomp.2019.03.003
Chicago
Inzucchi, Silvio E., and Vivian Fonseca. 2019. “Dethroning the King?: The Future of Metformin as First Line Therapy in Type 2 Diabetes.” Journal of Diabetes & Its Complications 33 (6): 462–64. doi:10.1016/j.jdiacomp.2019.03.003.